rHCT3-2

N/A

Report date: 2025/10/22 16:49:15

Base Information

Drug NamerHCT3-2
Drug Alias NamerHCT3-2
ClassificationOther
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsKeratoconus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheialife Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheialife Inc
Inactive CompaniesN/A
Active IndicationsKeratoconus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A